help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rao, C. V.
Right arrow Articles by Schultz, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rao, C. V.
Right arrow Articles by Schultz, G. S.

Journal of Clinical Endocrinology & Metabolism, Vol 58, 1034-1042, Copyright © 1984 by Endocrine Society


ARTICLES

Binding sites for epidermal growth factor in human fetal membranes

CV Rao, FR Carman Jr, N Chegini and GS Schultz

The present study demonstrates that human fetal membranes bind 125I- epidermal growth factor (125I-EGF), with chorion binding more than amnion. The chorion binding was also higher than that by decidua, but lower than in placenta. The lower binding by chorion compared to placenta was entirely attributable to a lower number of available EGF receptors and not to lower affinity. Chorion and placenta , but not amnion or decidua, from Cesarean section bound significantly more 125I- EGF when compared to tissues obtained after vaginal delivery. The binding of 125I-EGF to chorion exhibited dependency on time, temperature of incubation, pH of the incubation media, and amount of chorion protein. The 125I-EGF was not degraded during the binding reaction with chorion. The binding was specific in that unlabeled EGF inhibited 125I-EGF binding in a dose-dependent manner, whereas very high concentrations of other unlabeled hormones and growth factors had minimal effects on 125I-EGF binding. When some of these other hormones were tested for binding as tracers (125I-hCG, [3H]prostaglandin E1 and F2 alpha), neither chorion, amnion, decidua, nor placenta specifically bound these ligands. The 125I-EGF specific binding to chorion was saturable and a Scatchard plot of this data was curvilinear, which appears to be due to negative cooperativity. The apparent dissociation constant calculated from the initial slope of the plot was 0.20 nM, which is in excellent agreement with the concentration of unlabeled EGF required for half maximal inhibition of 125I-EGF binding, 0.26 nM. Autoradiography at the light microscope level revealed the presence of silver grains in amnion and chorion only when excess unlabeled EGF addition was withheld. The quantification of grains revealed the presence of a significantly (P less than 0.01) greater number of grains in chorion than in amnion, supporting the conclusion of the binding data. The physiological significance of EGF binding to fetal membranes and decidua is not known, but the considerable amount of EGF binding reported here suggests that they are target tissues for EGF.


This article has been cited by other articles:


Home page
EndocrinologyHome page
H.-M. Lee, V. Udupi, E. W. Englander, S. Rajaraman, R. J. Coffey Jr., and G. H. Greeley Jr.
Stimulatory Actions of Insulin-Like Growth Factor-I and Transforming Growth Factor-{alpha} on Intestinal Neurotensin and Peptide YY
Endocrinology, September 1, 1999; 140(9): 4065 - 4069.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Matsumoto, T. Yamamoto, H. Kurachi, Y. Nishio, T. Takeda, H. Homma, K.-i. Morishige, A. Miyake, and Y. Murata
Human Chorionic Gonadotropin-alpha Gene Is Transcriptionally Activated by Epidermal Growth Factor through cAMP Response Element in Trophoblast Cells
J. Biol. Chem., April 3, 1998; 273(14): 7800 - 7806.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. R. Gargiulo, F. S. Khan-Dawood, and M. Y. Dawood
Epidermal Growth Factor Receptors in Uteroplacental Tissues in Term Pregnancy before and after the Onset of Labor
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 113 - 117.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. W. Varner, G. A. Dildy, C. Hunter, D. J. Dudley, S. L. Clark, and M. D. Mitchell
Amniotic Fluid Epidermal Growth Factor Levels in Normal and Abnormal Pregnancies
Reproductive Sciences, January 1, 1996; 3(1): 17 - 19.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
I. Konishi, J. L. Fendrick, T. H. Parmley, J. G. Quirk JR, and T. J. O'Brien
Epidermal Growth Factor Enhances Secretion of the Ovarian Tumor-Associated Cancer Antigen CAI25 From the Human Amnion WISH Cell Line
Reproductive Sciences, January 1, 1994; 1(1): 89 - 96.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1984 by The Endocrine Society